The epidemic history of hepatitis C among injecting drug users in Flanders, Belgium
HCV-specific T-cell responses in injecting drug users
Hepatitis C in ethnic minority populations in England
Liver fibrosis on account of chronic hepatitis C is more severe in HIV-positive than HIV-negative patients despite antiretroviral therapy
Longitudinal changes in serum HBV DNA levels and predictors of progression during the natural course of HBeAg-negative chronic hepatitis B virus infection
In vitro effect of thymosin-alpha1 and interferon-alpha on Th1 and Th2 cytokine synthesis in patients with eAg-negative chronic hepatitis B
A complete genomic analysis of hepatitis B virus genotypes and mutations in HBeAg-negative chronic hepatitis B in China
Strategies for loading dendritic cells with hepatitis C NS5a antigen and inducing protective immunity
Is a 24 week treatment schedule with PegInterferon and Ribavirin too short for HCV genotype 3 cirrhotics?
FibroTest is effective in patients with normal transaminases, when accuracy is standardized on fibrosis stage prevalence
Performance of noninvasive markers for liver fibrosis is reduced in chronic hepatitis C with normal transaminases